FIELD: medicine.
SUBSTANCE: drainage contains the following ratio of components, in 1 ml of mixture: chitosan succinate 0.020-0.035 g; hyauronic acid dialehyde 0.005 g; mitomycin 0.001-0.003 ml; phosphate buffer - the remaining part.
EFFECT: application of the invention reduces inflammatory reaction and development of excessive processes of proliferation of surgery zone, improves intraocular fluid filtration and ensures normalisation of intraocular pressure.
4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DRAINAGE FOR TREATMENT OF GLAUCOMA | 2015 |
|
RU2610368C1 |
| METHOD FOR TREATING PRIMARY OPEN-ANGLE GLAUCOMA | 2019 |
|
RU2735378C1 |
| METHOD OF SURGICAL TREATMENT OF OPEN GLAUCOMA | 2012 |
|
RU2491043C1 |
| METHOD FOR SURGICAL MANAGEMENT OF OPEN-ANGLE GLAUCOMA | 2017 |
|
RU2662904C1 |
| SURGICAL METHOD FOR TREATING THE CASES OF OPEN ANGLE GLAUCOMA | 2003 |
|
RU2243751C1 |
| METHOD FOR SECONDARY OPEN ANGLE GLAUCOMA SURGERY | 2008 |
|
RU2369365C1 |
| METHOD FOR ACTIVATING THE UVEOSCLERAL PATHWAY OF OUTFLOW OF INTRAOCULAR LIQUID | 2018 |
|
RU2712640C1 |
| METHOD FOR MINIMALLY INVASIVE NONPENETRATING DEEP SCLERECTOMY IN OPEN-ANGLE GLAUCOMA | 2013 |
|
RU2527908C1 |
| SURGICAL METHOD FOR TREATING GLAUCOMA | 2000 |
|
RU2196555C2 |
| METHOD FOR PERFORMING MINIMALLY INVASIVE DEEP SCLERECTOMY | 2013 |
|
RU2548795C1 |
